FDA — authorised 1 February 2012
- Application: NDA202667
- Marketing authorisation holder: THEA PHARMA
- Local brand name: COSOPT PF
- Indication: SOLUTION/DROPS — OPHTHALMIC
- Status: approved
🇺🇸 timolol maleate and dorzolamide hydrochloride in United States
FDA authorised timolol maleate and dorzolamide hydrochloride on 1 February 2012
Marketing authorisation
Other Ophthalmology approved in United States
Frequently asked questions
Is timolol maleate and dorzolamide hydrochloride approved in United States?
Yes. FDA authorised it on 1 February 2012.
Who is the marketing authorisation holder for timolol maleate and dorzolamide hydrochloride in United States?
THEA PHARMA holds the US marketing authorisation.